Long-term (52–78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients

Long-term (52–78 weeks) treatment with colesevelam HCl added to metformin therapy in type 2 diabetes mellitus patients

Harold E BaysLouisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky, USAObjective: To evaluate the long-term safety, tolerability, and efficacy of colesevelam HCl (colesevelam) in type 2 diabetes mellitus patients receiving metformin monotherapy or metformin combination thera...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Bays HE
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Specialties of internal medicine
RC581-951
Acceso en línea:https://doaj.org/article/e3d6a34ccecb4e2cbc0af2f58703c244
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares